NEW MJ NEWS

AbbVie to Present at the Piper Sandler Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:30 a.m. CT.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-piper-sandler-healthcare-conference-301430238.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EDXC CEO Todd Davis Interviewed by Fox Business News NYC

Endexx CEO Todd Davis Interviewed by Fox Business News NYC CAVE CREEK,…

$TURV Reaffirms Ex-Dividend Date for GrowCo Share Distribution

Two Rivers Reaffirms Ex-Dividend Date for GrowCo Share Distribution July 1st to…

AYR Wellness Inc. (AYRWF) Reports Second Quarter 2023 Results

AYR Wellness Reports Second Quarter 2023 Results AYR Wellness Inc. (CSE: AYR.A,…

$CARA to Present at Formulations Conference

Cara Therapeutics to Present at 2nd Human Abuse Liability & Abuse-Deterrent Formulations…